Recommended content

Cannabis biz lawsuit could undermine rescheduling, DOJ says (Newsletter: October 14, 2024)

HI marijuana market study; MN psychedelics recommendations; TX medical cannabis report; CA hemp ban ruling; Willie Nelson tells Dallas to decrim

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going.

Join us at https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

The Department of Justice said in a new court brief that marijuana companies’ lawsuit challenging federal prohibition could “frustrate” cannabis rescheduling—suggesting that if they win, the government would “lack constitutional authority to regulate marijuana as a Schedule III drug for the same reasons that it could not regulate marijuana as a Schedule I drug.”

The Hawaii Office of Medical Cannabis Control and Regulation posted a request for proposals to analyze the “demand for cannabis, both for medical cannabis and adult-use,” as lawmakers continue to consider recreational marijuana legalization.

The Minnesota Psychedelic Medicine Task

Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment
Source

More news